Monday, March 09, 2020 9:23:51 PM
Tonight's $MILV share structure improvement news, confirms part of what I claimed would happen in Late November.
The Custodian just returned 640 Million of the 825 Million shares he issued to himself as a control block to insure he had total vote control of the shareholder's meeting and I presume to make sure no old paper from 11 years ago could be dug up or manufactured to try to illegally print shares.
It also confirms my claims in Late November last year that no R/S would be done.
That leaves the custodian with 185 Mil shares for his expenses, that could still be paid off in cash and those remaining 185 mil shares could be handed over to the folks bringing in the Biotech assets, in exchange for the Biotech assets.
It is still not 100% crystal clear what the final share structure will be, but it does vindicate my claims over 3 months ago that there would be no R/S and that most of the 825 mil shares would vanish, and 640 Mil of them just went Poof, and vanished.
That means the new officers/directors have at least 640 Mil shares of the AS unused now and available ensuring no need for a R/S. I kind of doubt the 185 mil shares will stay with the custodian either.
That is one one hell of a fat paycheck at say 10 to 25 cents a share. for now they are restricted and add to the market cap.
That leaves the current OS at 375 Mil shares and the float at 290 Mil shares.
The Custodian just returned 640 Million of the 825 Million shares he issued to himself as a control block to insure he had total vote control of the shareholder's meeting and I presume to make sure no old paper from 11 years ago could be dug up or manufactured to try to illegally print shares.
It also confirms my claims in Late November last year that no R/S would be done.
That leaves the custodian with 185 Mil shares for his expenses, that could still be paid off in cash and those remaining 185 mil shares could be handed over to the folks bringing in the Biotech assets, in exchange for the Biotech assets.
It is still not 100% crystal clear what the final share structure will be, but it does vindicate my claims over 3 months ago that there would be no R/S and that most of the 825 mil shares would vanish, and 640 Mil of them just went Poof, and vanished.
That means the new officers/directors have at least 640 Mil shares of the AS unused now and available ensuring no need for a R/S. I kind of doubt the 185 mil shares will stay with the custodian either.
That is one one hell of a fat paycheck at say 10 to 25 cents a share. for now they are restricted and add to the market cap.
That leaves the current OS at 375 Mil shares and the float at 290 Mil shares.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Recent NDTP News
- NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant • GlobeNewswire Inc. • 02/05/2026 02:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog • GlobeNewswire Inc. • 01/14/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s wholly owned subsidiary, Good Salt Life, Inc., Advances into AI-Robotics for Unmanned Hospital Disinfection • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- NDT Pharmaceuticals’ Wholly Owned Subsidiary Good Salt Life, Inc. Advances Toward Key Regulatory Milestones for Clean Republic® Multipurpose Disinfectant • GlobeNewswire Inc. • 01/08/2026 01:00:00 PM
- NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., Launches Brands PurrGuard® and Dog Gone Odor®, EPA-registered Odor-killing Bacteria Chemistry for Companion Animals • GlobeNewswire Inc. • 12/19/2025 01:36:01 PM
- Good Salt Life, Inc.'s Induction Charge Delivery Systems Deployed to Protect Show Horses from Widespread EHV-1 Outbreak • ACCESS Newswire • 11/26/2025 01:00:00 PM
- NDT Pharmaceuticals' Subsidiary, Good Salt(TM) Life, Secures Major Government Contract, Deploying Advanced Biosafety Ecosystem in Tennessee State Prisons • ACCESS Newswire • 11/24/2025 02:00:00 PM
- FatPipe, Jackpot Digital, and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 11/07/2025 02:00:00 PM
- 60 Degrees Pharmaceuticals and NDT Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV • ACCESS Newswire • 10/31/2025 01:00:00 PM
- Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5 • ACCESS Newswire • 10/30/2025 12:30:00 PM
- NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line • ACCESS Newswire • 10/21/2025 12:30:00 PM
- Baptist Hospital Enhances Patient Safety and Air Quality with Good Salt(TM) Life's ByoCart(TM) Disinfection System • ACCESS Newswire • 10/13/2025 12:30:00 PM
- Good Salt Life Expands EPA Registrations and Anticipates New Milestone • ACCESS Newswire • 10/09/2025 12:30:00 PM
- NDT Pharmaceuticals' Good Salt(TM) Life Subsidiary Unveils Scalable Antimicrobial Platform to Drive Health, Safety, and Sustainability Across Global Markets • ACCESS Newswire • 09/23/2025 01:10:00 PM
